This SNP is linked to the amino acid substitution, from proline (Pro) to leucine (Leu), and this change was shown to affect GPx1 activity, with the polymorphic variant (Leu) being less responsive to Se as observed in vitro, in human breast cancer cells (MCF-7) [33]. Here, GPX1 is linked to breast carcinoma.